Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid is a naturally occurring glycosaminoglycan found in various connective tissues, synovial fluid, and the vitreous humor of the eye. It acts as a lubricant and shock absorber. Synthetic preparations are used in medicine.
## Primary Indications
* **Intra-articular injection:** Osteoarthritis of the knee (pain relief).
* **Ophthalmic surgery:** Viscosurgical device for maintaining space, protecting corneal endothelium, and smoothing tissues during cataract and other anterior segment surgeries.
* **Dermal filler:** Soft tissue augmentation for cosmetic purposes.
* **Wound healing:** Topical preparations for management of certain chronic wounds.
## Adult Dosing
* **Intra-articular (knee osteoarthritis):** Dosing varies by product. Common regimens include:
* Single injection: 20 mg (2 mL) or 60 mg (6 mL) once.
* Multiple injections (e.g., 3 or 5 injections): 20 mg (2 mL) weekly for 3 or 5 weeks.
* Maximum dose: Generally limited to one course of treatment per joint per year. Refer to specific product labeling for maximum frequency and treatment cycles.
* **Ophthalmic surgery:** Typically administered via sterile syringe, volume depends on surgical procedure and surgeon preference.
* **Dermal filler:** Administered by trained professionals; volume depends on the area treated and desired correction.
* **Topical wound healing:** Frequency and concentration depend on wound type and product; usually applied once or twice daily.
## Pediatric Dosing
Dosing in pediatric patients is generally not established for intra-articular or ophthalmic indications. Safety and efficacy have not been adequately studied. Dermal fillers are contraindicated in pediatric patients.
## Dose Adjustments
No specific dose adjustments are required for hepatic or renal impairment.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Active infection at or near the injection site.
* Severe inflammatory conditions (e.g., severe synovitis) in the target joint.
* Ophthalmic indications: Contraindicated in patients with active intraocular inflammation or infection.
## Adverse Effects
* **Intra-articular:** Localized pain, swelling, stiffness, redness, warmth, itching at the injection site. Rarely, anaphylactic reactions or joint infection.
* **Ophthalmic:** Transient intraocular pressure increase, inflammation, edema.
* **Dermal filler:** Bruising, swelling, redness, pain, itching, infection, nodule formation, vascular occlusion.
* **Topical:** Localized irritation, redness.
## Key Drug Interactions
* **Intra-articular:** Concurrent use of disinfectants containing quaternary ammonium salts may cause precipitation. Avoid co-administration with other intra-articular injections.
* **Ophthalmic:** No significant interactions reported.
* **Dermal filler:** Concurrent use of anticoagulants or antiplatelet agents may increase the risk of bruising.
## Monitoring
* **Intra-articular:** Monitor for signs of infection (fever, chills, increased joint pain) or allergic reaction. Assess pain relief and functional improvement.
* **Ophthalmic:** Monitor intraocular pressure and signs of inflammation post-operatively.
* **Dermal filler:** Monitor for adverse reactions at the injection site.
## Clinical Pearls
* For intra-articular use, multiple injection regimens may provide longer-lasting pain relief than single injections for some patients.
* The effectiveness of hyaluronic acid for osteoarthritis of the knee can be variable, and patient selection is important.
* Proper aseptic technique is crucial for all injectable formulations to prevent infection.
* Always consult the specific product's prescribing information for detailed guidance on administration, indications, and potential risks.
---
*This information is intended for healthcare professionals. Please verify current prescribing information and consult relevant guidelines before making clinical decisions.*
